Initiation of adaptive immune responses by transcutaneous immunization

Area of Science:

• Immunology
• Vaccinology
• Dermatology

Background:

• Developing effective, accessible, and affordable vaccination strategies is crucial for combating infectious and malignant diseases globally.
• Current vaccination methods face challenges including cost, invasiveness, and needle-related risks, particularly in developing nations.
• Transcutaneous immunization (TCI) presents a promising alternative for antigen delivery, leveraging the skin's immune properties.

Purpose of the Study:

• To review the potential of transcutaneous immunization (TCI) as a novel vaccination approach.
• To highlight TCI's advantages, including enhanced immune responses, improved patient compliance, economic feasibility, and increased safety.
• To discuss methods for identifying new antigens and the role of adjuvants in TCI.

Main Methods:

• Review of existing literature on transcutaneous immunization (TCI) protocols.
• Discussion of antigen and adjuvant combinations for TCI.
• Exploration of antigen discovery methods like reverse vaccinology and mass spectrometry.
• Analysis of adjuvants such as cholera toxin (CT), heat-labile enterotoxin (LT), and R-837 (Imiquimod).

Main Results:

• TCI utilizes skin-resident antigen-presenting cells (APCs) for potent humoral and/or cellular immune responses.
• Topical application of antigen/adjuvant mixtures can improve compliance and reduce needle-associated risks.
• Dissecting antigens and adjuvants allows flexible combinations, unlike traditional methods.
• Small molecule adjuvants like R-837 can penetrate intact epidermis, while larger molecules like CT/LT require skin pretreatment.

Conclusions:

• TCI is a promising, non-invasive immunization strategy with potential for broad application against various diseases.
• Further research is needed to elucidate the specific cellular mechanisms within the skin-associated lymphoid tissue (SALT) involved in TCI.
• TCI offers a potentially safer, more economical, and patient-friendly alternative to conventional vaccination methods.